Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis
With increasing multidrug resistance and contraindication for corticosteroid use, the goal of this study was to develop thymosin beta-4 (Tβ4) as an adjunctive therapy to antibiotics for the treatment of bacterial keratitis that effectively promotes enhanced wound healing, host defense, and...
Main Authors: | Thomas W Carion, Abdul Shukkur Ebrahim, David Kracht, Aditya Agrawal, Eliisa Strand, Omar Kaddurah, Cody R. McWhirter, Gabriel Sosne, Elizabeth A. Berger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/7/10/145 |
Similar Items
-
Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in <i>Pseudomonas aeruginosa</i>-Induced Keratitis
by: Yuxin Wang, et al.
Published: (2021-10-01) -
Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during <i>Pseudomonas aeruginosa</i>-Induced Corneal Infection
by: Yuxin Wang, et al.
Published: (2021-12-01) -
Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in <i>Pseudomonas aeruginosa</i> Induced Keratitis
by: Thomas W. Carion, et al.
Published: (2020-09-01) -
Topical Tacrolimus as an adjunct to Conventional Therapy for Stromal Herpetic Keratitis: a Randomized Clinical Trial
by: Mitra Akbari, et al.
Published: (2019-10-01) -
A Novel Combination Therapy Tβ4/VIP Protects against Hyperglycemia-Induced Changes in Human Corneal Epithelial Cells
by: Abdul Shukkur Ebrahim, et al.
Published: (2023-11-01)